The addition of dexmedetomidine to the midazolam-meperidine regimen provided better sedative efficacy and a superior safety profile during ERCP compared with a midazolam-meperidine regimen.This trial was registered at ClinicalTrials.gov Identifier ( NCT01404689 ) .